Research covered glass formulations, sizing chemicals, fiber products, composite applications, machinery, cleaner production and intelligent manufacturing. Sizing and formulation are disclosed research areas; the report does not give enough grade-level specifications or independent performance tests to establish a universal technical advantage. FY2020 R&D expenditure was CNY 341,662,980.95, equal to 2.93% of revenue, and was entirely expensed: capitalized R&D was zero. The 1,766 research personnel represented 15.07% of employees. The report also describes patent grants and approval of assistance for a China–Egypt joint laboratory, already recorded separately; patents and an approved laboratory initiative are not commercial shipments. Reported material cost was CNY 2,406,124,579.58, up 19.96%. The table’s 31.15% cost share is consistent with total consolidated operating cost, not the narrower fiber-cost row; it is not presented here as the material share of fiber-only cost. The disclosure does not allocate research or material spending to individual production lines, or quantify savings achieved by each technical initiative.
- Research expenditure / 2020 / FY2020 issuer management disclosure; original currency, unit, product/region/company denominator and balance/flow scope retained. Not project allocation or a complete audited note reconciliation.
- RMB 341,662,980.95
- Capitalized research expenditure / 2020 / FY2020 issuer management disclosure; original currency, unit, product/region/company denominator and balance/flow scope retained. Not project allocation or a complete audited note reconciliation.
- RMB 0
- Research personnel / 2020 / FY2020 issuer management disclosure; original currency, unit, product/region/company denominator and balance/flow scope retained. Not project allocation or a complete audited note reconciliation.
- 1,766 persons
- Reported material cost / 2020 / FY2020 issuer management disclosure; original currency, unit, product/region/company denominator and balance/flow scope retained. Not project allocation or a complete audited note reconciliation.
- RMB 2,406,124,579.58